<?OLF?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Pharmacol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1552-4604</journal-id><journal-id journal-id-type="publisher-id">JCPH</journal-id><journal-title-group><journal-title>Journal of Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0091-2700</issn><issn pub-type="epub">1552-4604</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1002/jcph.1673</article-id><article-id pub-id-type="publisher-id">JCPH1673</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>A Comprehensive Updated Review on SARS&#x02010;CoV&#x02010;2 and COVID&#x02010;19</article-title></title-group><contrib-group><contrib id="jcph1673-cr-0001" contrib-type="author"><name><surname>Ren</surname><given-names>Yunzhao R.</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="jcph1673-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jcph1673-cr-0002" contrib-type="author"><name><surname>Golding</surname><given-names>Amit</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="jcph1673-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jcph1673-cr-0003" contrib-type="author"><name><surname>Sorbello</surname><given-names>Alfred</given-names></name><degrees>DO, MPH</degrees><xref ref-type="aff" rid="jcph1673-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="jcph1673-cr-0004" contrib-type="author"><name><surname>Ji</surname><given-names>Ping</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="jcph1673-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="jcph1673-cr-0005" contrib-type="author"><name><surname>Chen</surname><given-names>Jianmeng</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="jcph1673-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="jcph1673-cr-0006" contrib-type="author"><name><surname>Bhawana</surname><given-names>Saluja</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="jcph1673-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="jcph1673-cr-0007" contrib-type="author"><name><surname>Witzmann</surname><given-names>Kimberly</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="jcph1673-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="jcph1673-cr-0008" contrib-type="author"><name><surname>Arya</surname><given-names>Vikram</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="jcph1673-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="jcph1673-cr-0009" contrib-type="author"><name><surname>Reynolds</surname><given-names>Kellie S.</given-names></name><degrees>PharmD</degrees><xref ref-type="aff" rid="jcph1673-aff-0008">
<sup>8</sup>
</xref></contrib><contrib id="jcph1673-cr-0010" contrib-type="author"><name><surname>Choi</surname><given-names>Su&#x02010;Young</given-names></name><degrees>PharmD, PhD</degrees><xref ref-type="aff" rid="jcph1673-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="jcph1673-cr-0011" contrib-type="author"><name><surname>Nikolov</surname><given-names>Nikolay</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="jcph1673-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jcph1673-cr-0012" contrib-type="author" corresp="yes"><name><surname>Sahajwalla</surname><given-names>Chandrahas</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="jcph1673-aff-0009">
<sup>9</sup>
</xref><address><email>chandrahas.sahajwalla@fda.hhs.gov</email></address></contrib></contrib-group><aff id="jcph1673-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Division of Inflammation and Immune Pharmacology</named-content>
<institution>Office of Clinical Pharmacology</institution>
<named-content content-type="organisation-division">Office of Translational Science</named-content>
<named-content content-type="organisation-division">Center for Drug Evaluation and Research</named-content>
<named-content content-type="organisation-division">FDA</named-content>
</aff><aff id="jcph1673-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Division of Rheumatology and Transplant Medicine</named-content>
<institution>Office of Immunology and Inflammation</institution>
<named-content content-type="organisation-division">Office of New Drugs</named-content>
<named-content content-type="organisation-division">Center for Drug Evaluation and Research</named-content>
<named-content content-type="organisation-division">FDA</named-content>
</aff><aff id="jcph1673-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Office of Translational Sciences</named-content>
<institution>Center for Drug Evaluation and Research</institution>
<named-content content-type="organisation-division">FDA</named-content>
</aff><aff id="jcph1673-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Division of Inflammation and Immune Pharmacology</named-content>
<institution>Office of Clinical Pharmacology</institution>
<named-content content-type="organisation-division">Office of Translational Sciences</named-content>
<named-content content-type="organisation-division">Center for Drug Evaluation and Research</named-content>
<named-content content-type="organisation-division">FDA</named-content>
</aff><aff id="jcph1673-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Division of Inflammation and Immune Pharmacology</named-content>
<institution>Office of Clinical Pharmacology</institution>
<named-content content-type="organisation-division">Office of Translational Sciences Center for Drug Evaluation and Research</named-content>
<named-content content-type="organisation-division">FDA</named-content>
</aff><aff id="jcph1673-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Office of Bioequivalence</named-content>
<institution>Office of Generic Drugs</institution>
<named-content content-type="organisation-division">Center for Drug Evaluation and Research</named-content>
<named-content content-type="organisation-division">FDA</named-content>
</aff><aff id="jcph1673-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">Division of Infectious Disease Pharmacology</named-content>
<institution>Office of Clinical Pharmacology</institution>
<named-content content-type="organisation-division">Office of Translational Sciences</named-content>
<named-content content-type="organisation-division">Center for Drug Evaluation and Research</named-content>
<named-content content-type="organisation-division">FDA</named-content>
</aff><aff id="jcph1673-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Division of Infectious Disease Pharmacology</named-content>
<institution>Office of Clinical Pharmacology</institution>
<named-content content-type="organisation-division">Office of Translational Sciences</named-content>
<named-content content-type="organisation-division">Center for Drug Evaluation and Research</named-content>
<named-content content-type="organisation-division">FDA</named-content>
<named-content content-type="organisation-division">Fellow of the American College of Clinical Pharmacology</named-content>
</aff><aff id="jcph1673-aff-0009">
<label><sup>9</sup></label>
<named-content content-type="organisation-division">Division of Inflammation and Immune Pharmacology</named-content>
<institution>Office of Clinical Pharmacology</institution>
<named-content content-type="organisation-division">Office of Translational Sciences</named-content>
<named-content content-type="organisation-division">Center for Drug Evaluation and Research</named-content>
<named-content content-type="organisation-division">FDA</named-content>
<named-content content-type="organisation-division">Fellow of the American College of Clinical Pharmacology</named-content>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Corresponding Author</bold><break/>Chandrahas Sahajwalla, 10903 New Hampshire Ave, Silver Spring, MD 20993, Building 51, Room3144<break/>Email: <email>chandrahas.sahajwalla@fda.hhs.gov</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>5</month><year>2020</year></pub-date><elocation-id>10.1002/jcph.1673</elocation-id><history><date date-type="received"><day>06</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>20</day><month>5</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020, The American College of Clinical Pharmacology <copyright-statement>--><copyright-statement content-type="article-copyright">This article is protected by copyright. All rights reserved</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JCPH-9999-na.pdf"/><abstract><title>Abstract</title><p>This literature review aims to provide a comprehensive current summary of the pathogenesis, clinical features, disease course, host immune responses, and current investigational antiviral and immunomodulatory pharmacotherapies, in order to facilitate the development of future therapies and measures for prevention and control.</p><p>This article is protected by copyright. All rights reserved</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jcph1673-kwd-0001">COVID&#x02010;19</kwd><kwd id="jcph1673-kwd-0002">SARS&#x02010;CoV&#x02010;2</kwd><kwd id="jcph1673-kwd-0003">review</kwd><kwd id="jcph1673-kwd-0004">clinical characteristics</kwd><kwd id="jcph1673-kwd-0005">treatment</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><page-count count="1"/><word-count count="16105"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>accepted-manuscript</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:10.06.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="jcph1673-note-0001"><p>Chandrahas Sahajwalla is a Fellow of the American College of Clinical Pharmacology</p></fn><fn id="jcph1673-note-0002"><p>Vikram Arya is a Fellow of the American College of Clinical Pharmacology</p></fn><fn id="jcph1673-note-0003"><p>Disclaimer: The views expressed are those of the authors and do not necessarily represent the views of the US FDA or the US Government. The COVID&#x02010;19 publications are evolving at a rapid pace and this manuscript is based on papers available at the time of submission to the journal. Therefore, readers are advised to monitor the literature for the most current findings.</p></fn><fn id="jcph1673-note-0032"><p>This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jcph.1673">https://doi.org/10.1002/jcph.1673</ext-link>
</p></fn></fn-group></notes></front></article>